Profusa Q3 Loss Narrows to $4.95M; Cash Falls to $0.34M With Going Concern Doubt
PFSA is trading near its 52-week low of $0.402 (9.9% above the low) on light trading volume (0.1× avg).
Summary
Profusa's Q3 loss narrowed to $4.95 million on lower expenses, but cash fell to $0.34 million and management reiterated going-concern doubt. Heavy further dilution looms from the $28.3 million G3 option asset, a 14.7 million-share preferred overhang, and November debt conversions at $0.46.
Key Events · Earnings and Guidance · PFSA
-
Q3 Loss Narrows to $4.95M
Net loss fell to $4.95 million from $26.09 million a year earlier, helped by a $7.35 million fair-value gain on convertible notes; the nine-month loss was $17.16 million versus $31.15 million.
-
Cash Drops to $0.34M
Cash was $0.34 million at September 30 versus $1.78 million at December 31, 2025, with a working capital deficit of about $20.7 million and substantial doubt about going concern reiterated.
-
G3 Option Asset at $28.3M
The G3 call option is carried as a $28.3 million non-current asset funded by 50,280 common shares and 52,903.566 Series A preferred shares; exercise still requires $30 million of financing and other conditions.
-
14.7M-Share Preferred Overhang
58,832.859 Series A preferred shares are outstanding and convertible into 14,708,215 common shares once stockholders approve, against 5,681,947 shares outstanding as of November 13, 2026.
Analysis · PFSA · Industrial Applications And Services
The headline improvement in Profusa's third quarter is largely accounting noise: the loss narrowed sharply to $4.95 million from $26.09 million a year earlier, but a $7.35 million fair-value gain on convertible notes and a $7.89 million loss on debt extinguishment offset each other, while operating expenses fell 78% to $4.85 million. Liquidity is the real story. Cash stood at just $0.34 million on September 30 against a $20.7 million working capital deficit, and management again says substantial doubt exists about continuing as a going concern. Support comes from Ascent's PIPE facility, with $8.4 million still available at investor discretion, and an $86.9 million equity line, both of which depend on the counterparty and on a share price that has collapsed. Largest item on the balance sheet is the $28.3 million G3 call option asset, funded entirely with stock; it converts into roughly 14.7 million common shares if holders approve, enormous dilution against 5.68 million shares currently outstanding. Subsequent events show that dilution already accelerating: NVAC converted its remaining note into 2.15 million shares at $0.46 on the filing date, and October amendments cut conversion floors to $0.338 and $0.20, so further conversions will issue even more shares at lower prices.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PFSA was trading at $0.44 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $267.7K. The 52-week trading range was $0.40 to $1,539.75. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.